학술논문
Safety and efficacy of dacomitinib in Korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: A phase I/II trial
Document Type
Article
Author
Source
In: Journal of Thoracic Oncology . (Journal of Thoracic Oncology, 1 October 2014, 9(10):1523-1531)
Subject
Language
English
ISSN
15561380
15560864
15560864